HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...

You have a vague idea that something is cut but what is it? And how will the procedure affect down there as well as your sex ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Legislation that would ban mRNA vaccinations statewide — including the Covid-19 vaccine — drew equal parts support and opposition during a House Judiciary Committee hearing on Friday.

Yet, uptake levels of vaccines in the US would tell a different story. As of mid-December, only 20.9 percent of adults in the ...

Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know ...

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

It does have my birthday, however, and I have made the case that it should be declared a federal holiday ... which are located throughout the body and can trigger the production of antibodies. The ...

Towana Looney of Alabama is 'going strong and feeling great' after a pig kidney transplant. No one has lived longer with an ...

The future of medicine may very well lie in the personalization of health care—knowing exactly what an individual needs and ...

Caltech manufactures wearable sweat sensors equipped with special nanoparticles that inkjet print a biomarker, ...

“The additional capital will help us further advance our discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein ... overcome the existing challenges ...